Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Humanized monoclonal antibody directed against the carcinoembryonic antigen data

IMMU (Morris Plains, N.J.) said it had successfully targeted the antibody in

Read the full 125 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE